We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – News and Features

News

Oncolytics Biotech® Inc. Announces Phase I Multiple Myeloma Cancer Study

NCI has agreed to sponsor a Phase I study of REOLYSIN® alone in patients with relapsed multiple myeloma.
News

New Radioisotope will Improve Cancer Therapy

Neutrons from a research reactor are enabling R&D for new cancer therapies that will be more targeted and cause less collateral damage in healthy tissue.
News

Debiopharm and Aurigene Sign Agreement for the Development and Commercialization of Debio 1142

The Debio 1142 project aims at developing inhibitors targeting a key oncology pathway, which plays essential roles in various solid tumours.
News

Cell Therapeutics Acquires Exclusive Marketing and Co-Development Rights in the Americas to Chromas' Tosedostat

Phase III pivotal trial in acute myeloid leukemia expected to start in Q4 2011.
News

Collaboration to Apply rAAV Gene Targeting in Mouse Embryonic Stem Cells and Research into EGFR-Therapy Resistance

Horizon Discovery announces that it has entered into a three-year collaboration with the Fox Chase Cancer Center.
News

Scripps Research Scientists find E. Coli Enzyme must move to Function

Slight oscillations lasting just milliseconds have a huge impact on an enzyme's function, according to a new study by Scripps Research Institute scientists.
News

4SC Announces Treatment of First Patient in Phase I TOPAS Study with the Selective HDAC Inhibitor 4SC-202

The study evaluate the safety, pharmacokinetics and clinical efficacy of 4SC-202 in patients with advanced hematological indications, including AML, ALL, CLL, MM, MDS and lymphomas.
News

'Good Cholesterol' Nanoparticles Seek and Destroy Cancer Cells

Scientists package HDL with gene-silencing siRNA to target tumors, spare normal tissue.
News

CT Atlantic AG to Present Positive Preclinical Results for NY-ESO-1 HD-MAB® at Forthcoming AACR Annual Meeting

CTA001.12D7 efficiently inhibits the growth of tumors in mice acting synergistically with chemotherapy.
News

Algeta Enters Research Collaboration with Genzyme to Evaluate Thorium Platform

Genzyme provides access to a novel tumor-targeting antibody, and Algeta will provide access to its Thorium platform to attach the alpha emitting payload thorium-227.
Advertisement